AstraZeneca, Eli Lilly, and Vertex will be among customers from leading pharmas who will discuss Compound Combination, HTS, and label-free data analysis.
Basel, Switzerland (PRWEB) September 04, 2013
Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that four Genedata Screener User Group Meetings will be held in Asia, Europe, and North America during September 2013. Annual global meetings bring together scientists, lab heads, bioinformaticians, and research IT managers from leading pharmaceutical and biotechnology companies, academic institutions, and contract research organizations. With more than half of the top 25 pharmaceutical companies using Genedata Screener, industry experts from AstraZeneca, Eli Lilly, and Vertex Pharmaceuticals will be among the featured speakers who represent a growing community of researchers who run screening experiments for Compound Combination, Ion Channel, high-throughput screening, high-content screening, and label-free data analysis.
“Genedata Screener User Group Meetings underscore one of the core values at Genedata – namely that of collaboration,” said Dr. Othmar Pfannes, CEO of Genedata. “They provide real-life opportunities for Screener users to meet their peers, learn, share experiences, and discover more applications for Genedata Screener. This level of global collaboration fuels continuous technology innovations from Genedata.”
The 2013 Genedata Screener User Group Meetings will also feature Best Practice sessions on topics such as “Feature Selection in HCS Assays” and “Compound Profiling with Hit Profiler.” Meetings will be held in: Tokyo, Japan (Sept. 3); Basel, Switzerland (Sept. 10); Boston, MA (Sept.17); and San Francisco, CA (Sept. 19). Inquiries may be sent to: ugm(at)genedata(dot)com.
About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US. http://www.genedata.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11083970.htm
Via: SaaS Newswire / PRWeb
